Results 11 to 20 of about 216,694 (240)

Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis [PDF]

Arquivos de Neuro-Psiquiatria, 2016
Sleep disorders in patients with multiple sclerosis have various causes and interfere with daytime wakefulness. This study assessed the correlation between fatigue, excessive daytime sleepiness and level of disability.
Douglas Martins Braga, Gilmar Fernandes do Prado, Denis Bernardi Bichueti, Enedina Maria Lobato de Oliveira   +3 more
doaj   +4 more sources

Meta‐analysis of the use of Ofatumumab in the treatment of relapsing‐remitting multiple sclerosis

Medicine Advances, 2023
Background Ofatumumab is the first monoclonal antibody developed specifically for treating relapsed multiple sclerosis (RMS). This disease (Multiple Sclerosis) includes relapsing–remitting multiple sclerosis (RRMS), a chronic autoimmune illness that ...
Peter Olujimi Odutola, Peter Oluwatobi Olorunyomi, Olanrewaju Olamide Olatawura, Ifeoluwapo Olorunyomi, Olukayode Oluyinka Madojutimi, Uju Okeke, Ayomide O. Fatunsin, Victoria Eneh   +7 more
doaj   +1 more source

A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis

Multiple Sclerosis, 2021
Background: REFINE was an exploratory, dose- and frequency-blinded, prospective, randomized, dose-ranging study in relapsing–remitting multiple sclerosis (RRMS) patients.
M. Trojano, L. Ramió-Torrentá, Luigi M. E. Grimaldi, C. Lubetzki, S. Schippling, Karleyton C. Evans, Zheng Ren, K. Muralidharan, S. Licata, Arie R. Gafson   +9 more
semanticscholar   +1 more source

Sensorimotor function in progressive multiple sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2020
Background A sensitive test reflecting subtle sensorimotor changes throughout disease progression independent of mobility impairment is currently lacking in progressive multiple sclerosis. Objectives We examined non-ambulatory measures of upper and lower
Jules D Miehm, John Buonaccorsi, Jongil Lim, Sumire Sato, Caitlin Rajala, Julianna Averill, Farnaz Khalighinejad, Carolina Ionete, Stephanie L Jones, Jane A Kent, Richard EA van Emmerik   +10 more
doaj   +1 more source

Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis

Brain Communications, 2022
Myelin-sensitive MRI such as magnetization transfer imaging has been widely used in multiple sclerosis. The influence of methodology and differences in disease subtype on imaging findings is, however, not well established.
E. York, M. Thrippleton, R. Meijboom, D. Hunt, A. Waldman   +4 more
semanticscholar   +1 more source

A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis

Nature Communications, 2021
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) with the majority of cases characterised by relapsing/remitting (RRMS) attacks of neurologic dysfunction followed by variable resolution.
Eoin F. McKinney, Iona Cuthbertson, Kristina M. Harris, D. Smilek, C. Connor, G. Manferrari, E. J. Carr, S. Zamvil, Kenneth G. C. Smith   +8 more
semanticscholar   +1 more source

Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis. [PDF]

PLoS ONE, 2016
Conduction along the optic nerve is often slowed in multiple sclerosis (MS). This is typically assessed by measuring the latency of the P100 component of the Visual Evoked Potential (VEP) using electroencephalography.
Hanni S M Kiiski, Sinéad Ní Riada, Edmund C Lalor, Nuno R Gonçalves, Hugh Nolan, Robert Whelan, Róisín Lonergan, Siobhán Kelly, Marie Claire O'Brien, Katie Kinsella, Jessica Bramham, Teresa Burke, Seán Ó Donnchadha, Michael Hutchinson, Niall Tubridy, Richard B Reilly   +15 more
doaj   +1 more source

Primary progressive multiple sclerosis in the Polish population

Aktualności Neurologiczne, 2017
Objectives: The aim of the study was the epidemiological analysis and evaluation of selected clinical and sociodemographic factors in Polish patients with primary progressive multiple sclerosis.
Waldemar Brola, Piotr Sobolewski, Stanisław Flaga, Małgorzata Fudala, Andrzej Potemkowski   +4 more
doaj   +1 more source

Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis

Neurology: Neuroimmunology & Neuroinflammation, 2021
Objective To assess the safety and efficacy of epigallocatechin-3-gallate (EGCG) add-on to glatiramer acetate (GA) in patients with relapsing-remitting multiple sclerosis (RRMS).
J. Bellmann-Strobl, F. Paul, J. Wuerfel, J. Dörr, C. Infante-Duarte, Elmira Heidrich, Benedict Körtgen, A. Brandt, Caspar Pfüller, Helena Radbruch, R. Rust, Volker Siffrin, O. Aktas, C. Heesen, J. Faiss, F. Hoffmann, M. Lorenz, B. Zimmermann, Sergiu Groppa, K. Wernecke, F. Zipp   +20 more
semanticscholar   +1 more source

EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN

Вопросы современной педиатрии, 2013
Aim: to evaluate the impact of subcutaneous interferon β-1a on matrix metalloproteinases 3, 8, 9 (MMP), cytokines (tumor necrosis factor α — TNF α, and transforming growth factor β1 — TGF β1) levels in serum of children with relapsing-remitting multiple ...
L. M. Kuzenkova, L. A. Pak, V.M. Studenikin, N. N. Shatilova, B. I. Bursagova, I. E. Smirnova   +5 more
doaj   +1 more source